Merck and Eisai say two lung-cancer trials failed to meet their main goals
Merck and Japanese partner Eisai said Friday that two late-stage trials of a treatment for a certain type of non-small lung cancer failed to meet their primary goals in a disappointing outcome, but said they would continue to push ahead with their research. The companies said the LEAP-006 and…#merck #eisai #keytruda #lenvima #nsclc #gregorylubiniecki #rcc
Source: Reuters: Health - Category: Consumer Health News Source Type: news
More News: Cancer | Cancer & Oncology | Health | Japan Health | Lung Cancer | Merck | Non-Small Cell Lung Cancer